Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

LFWD

Lifeward Ltd

Feb 06 • 04:00PM ET

0.5700

+0.0272 5.01 %

Healthcare • Medical Devices • USA • NASD

Peers: ISRG GMED PODD CUTR ARAY HAE IART BIO MASI STXS

Index	-	P/E	-	EPS (ttm)	-2.98	Insider Own	2.42%	Shs Outstand	18.29M	Perf Week	-5.79%
Market Cap	10.43M	Forward P/E	-	EPS next Y	-0.23	Insider Trans	-0.36%	Shs Float	17.85M	Perf Month	-10.28%
Enterprise Value	8.48M	PEG	-	EPS next Q	-0.08	Inst Own	4.24%	Short Float	9.70%	Perf Quarter	2.70%
Income	-29.84M	P/S	0.43	EPS this Y	73.27%	Inst Trans	2.74%	Short Ratio	3.39	Perf Half Y	-16.16%
Sales	24.50M	P/B	0.75	EPS next Y	74.16%	ROA	-86.58%	Short Interest	1.73M	Perf YTD	-1.14%
Book/sh	0.76	P/C	4.76	EPS next 5Y	80.42%	ROE	-127.95%	52W High	2.95 -80.68%	Perf Year	-58.99%
Cash/sh	0.12	P/FCF	-	EPS past 3/5Y	-21.43% 29.33%	ROIC	-232.38%	52W Low	0.50 13.77%	Perf 3Y	-90.21%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	62.63% 39.41%	Gross Margin	37.49%	Volatility	6.29% 7.54%	Perf 5Y	-96.35%
Dividend TTM	-	EV/Sales	0.35	EPS Y/Y TTM	-32.93%	Oper. Margin	-70.24%	ATR (14)	0.05	Perf 10Y	-99.97%
Dividend Ex-Date	-	Quick Ratio	1.13	Sales Y/Y TTM	-2.02%	Profit Margin	-121.82%	RSI (14)	40.30	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.92	EPS Q/Q	43.81%	SMA20	-11.05%	Beta	0.15	Target Price	7.25
Payout	-	Debt/Eq	0.02	Sales Q/Q	1.09%	SMA50	-11.33%	Rel Volume	0.38	Prev Close	0.54
Employees	80	LT Debt/Eq	0.01	Earnings	Nov 14 BMO	SMA200	-27.66%	Avg Volume	510.94K	Price	0.57
IPO	Sep 12, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.00% -1.84%	Trades		Volume	196,098	Change	5.01%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-10-25	Initiated	Laidlaw	Buy	$10
Apr-03-17	Downgrade	Barclays	Equal Weight → Underweight	$2.50 → $1.50
Dec-16-16	Initiated	Oppenheimer	Outperform
Jul-15-16	Initiated	Piper Jaffray	Overweight	$10
May-22-15	Upgrade	Canaccord Genuity	Hold → Buy	$11 → $17
May-08-15	Reiterated	Barclays	Equal Weight	$20 → $13
Oct-07-14	Initiated	Barclays	Equal Weight	$28

Jan-13-26 08:00AM	Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company (GlobeNewswire) +9.22%
Dec-19-25 04:05PM	Lifeward Appoints Bob Marshall as Chairman of the Board (GlobeNewswire)
Dec-17-25 08:00AM	Lifeward Expands International Distribution of its ReWalk Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates (GlobeNewswire)
Dec-03-25 08:00AM	Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval (GlobeNewswire) +25.45%
Nov-17-25 08:00AM	UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton (GlobeNewswire)
04:01PM	Loading…
Nov-14-25 04:01PM	Lifeward Ltd (LFWD) Q3 2025 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com) +14.87%
08:11AM	Lifeward: Q3 Earnings Snapshot (Associated Press Finance)
08:00AM	Lifeward Ltd. Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-13-25 07:31AM	Lifeward Ltd (LFWD) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-10-25 07:00AM	Lifeward to Report Third Quarter Financial Results on November 14, 2025 (GlobeNewswire)
Sep-09-25 08:45AM	Lifeward Achieves European Approval for Latest ReWalk Exoskeleton (Zacks)
08:30AM	First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton (GlobeNewswire)
Sep-08-25 08:30AM	Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton (GlobeNewswire)
Aug-14-25 09:10AM	Lifeward (LFWD) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -14.64%
08:06AM	Lifeward: Q2 Earnings Snapshot (Associated Press Finance)
08:00AM	Loading…
08:00AM	Lifeward Ltd. Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-13-25 08:00AM	Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership (GlobeNewswire)
Aug-12-25 06:00PM	Rigetti Computing, Inc. (RGTI) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Aug-07-25 05:30PM	Lifeward to Report Second Quarter Financial Results on August 14, 2025 (GlobeNewswire)
05:25PM	Turtle Beach (TBCH) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Aug-06-25 10:50AM	Verb Technology Company, Inc. (VERB) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Aug-05-25 06:20PM	8x8 (EGHT) Q1 Earnings Match Estimates (Zacks)
Aug-04-25 08:30AM	Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region (GlobeNewswire)
Jul-07-25 11:00AM	MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion (PR Newswire)
Jun-26-25 04:15PM	Lifeward Announces Closing of $2.6 Million Public Offering (GlobeNewswire) +15.16%
09:15AM	Lifeward prices 4M shares at 65c in public offering (TipRanks)
Jun-25-25 09:10AM	Lifeward Announces Pricing of $2.6 Million Public O?ering (GlobeNewswire) -36.80%
Jun-24-25 04:05PM	Administrative Law Judge Determines ReWalk Personal Exoskeleton is "Reasonable and Necessary" for Medicare Beneficiary (GlobeNewswire)
May-20-25 08:00AM	Sidoti Events, LLC's Virtual May Micro-Cap Conference (ACCESSWIRE)
May-19-25 08:30AM	Lifeward Names Mark Grant as New CEO (GlobeNewswire)
06:00AM	Loading…
06:00AM	Lifeward to Present at Sidoti Virtual Investor Conference on May 21 (GlobeNewswire)
May-16-25 03:08AM	Lifeward Ltd (LFWD) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
May-15-25 09:15AM	Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -10.42%
08:00AM	Lifeward Ltd. Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-08-25 08:30AM	Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons (GlobeNewswire)
May-07-25 04:30PM	Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025 (GlobeNewswire)
Apr-29-25 08:30AM	First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton (GlobeNewswire)
Apr-24-25 08:30AM	Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton (GlobeNewswire)
Apr-16-25 07:13AM	LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7 (Zacks)
Apr-15-25 08:15AM	Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market (GlobeNewswire)
Mar-23-25 08:40AM	Lifeward Ltd. (LFWD): Among the Penny Stocks With Huge Upside Potential According to Analysts (InsiderMonkey)
Mar-13-25 09:15AM	FDA Issues Clearance for ReWalk 7 Exoskeleton (GlobeNewswire) +8.84%
Mar-08-25 02:03AM	Lifeward Ltd (LFWD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com)
Mar-07-25 08:00AM	Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-06-25 08:00AM	Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk Exoskeleton (GlobeNewswire) -8.14%
Mar-05-25 08:00AM	Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use (GlobeNewswire)
Feb-28-25 08:00AM	Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025 (GlobeNewswire)
Feb-19-25 09:10AM	Lifeward Announces CEO Transition (GlobeNewswire) -8.00%
Feb-06-25 08:20AM	Lifeward finalizes agreement with BARMER (TipRanks)
Feb-05-25 08:00AM	Lifeward Finalizes Personal Exoskeleton Reimbursement Agreement with BARMER, Adding 8.5 Million Covered Lives in Germany (GlobeNewswire)
Feb-04-25 08:00AM	Lifeward to Host Virtual Investor Event to Discuss Commercial Strategy, Key Initiatives, and Financial Outlook on February 20, 2025 (GlobeNewswire)
Jan-13-25 08:30AM	Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities (GlobeNewswire) -17.68%
07:45AM	Lifeward Cancels Its Extraordinary General Meeting of Shareholders (GlobeNewswire)
Jan-08-25 04:15PM	Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -10.41%
Jan-07-25 08:05AM	Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -27.30%
Dec-27-24 05:49PM	Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders (GlobeNewswire) +18.24% -7.46%
Nov-19-24 08:30AM	Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons (GlobeNewswire) +5.14%
Nov-13-24 02:08AM	Lifeward Ltd (LFWD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... (GuruFocus.com) -16.32%
Nov-12-24 08:00AM	Lifeward Ltd. Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-07-24 04:05PM	Lifeward Announces Appointment of Robert J. Marshall to Its Board of Directors (GlobeNewswire)
Nov-05-24 04:38PM	Lifeward to Report Third Quarter Financial Results on November 12, 2024 (GlobeNewswire) -7.24%
Nov-04-24 08:00AM	Lifeward Streamlines U.S. Operations in Next Phase of Growth and Operational Efficiencies (GlobeNewswire)
Oct-24-24 04:30PM	Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024 (GlobeNewswire)
Sep-24-24 05:00PM	Lifeward Launches Direct Sales of AlterG Product Line in Germany (GlobeNewswire)
Sep-12-24 08:30AM	ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd. (GlobeNewswire)
Sep-10-24 08:30AM	Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research (GlobeNewswire)
Sep-05-24 08:30AM	Lifeward's First Annual Step Challenge Donates 5,000 to German Association for People Living with Spinal Cord Injury (GlobeNewswire)
Sep-04-24 04:15PM	Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-15-24 08:00AM	Lifeward Reports Second Quarter 2024 Financial Results (GlobeNewswire) +30.66%
Aug-08-24 04:15PM	Lifeward to Report Second Quarter Financial Results on August 15, 2024 (GlobeNewswire) -6.52%
Jul-02-24 04:30PM	Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors (GlobeNewswire)
Jun-26-24 08:30AM	Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line Introducing AlterG NEO (GlobeNewswire)
Jun-11-24 10:50AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE)
Jun-04-24 04:30PM	Lifeward to Present at Sidoti Virtual Investor Conference on June 12 (GlobeNewswire)
May-28-24 03:32AM	LFWD Stock Earnings: Rewalk Robotics Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
May-16-24 08:18AM	ReWalk Robotics Ltd. (NASDAQ:LFWD) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-15-24 09:10AM	ReWalk Robotics (LFWD) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
08:00AM	Lifeward Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-14-24 12:00PM	ReWalk (LFWD) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
May-07-24 04:30PM	Lifeward to Report First Quarter Financial Results on May 15, 2024 (GlobeNewswire) +7.47%
May-02-24 10:01AM	Earnings Preview: ReWalk Robotics (LFWD) Q1 Earnings Expected to Decline (Zacks)
Apr-26-24 10:19AM	Should Lifeward (LFWD) be in Your Portfolio Ahead of Q1 Earnings? (Zacks)
Apr-23-24 09:55AM	Bears are Losing Control Over ReWalk (LFWD), Here's Why It's a 'Buy' Now (Zacks)
Apr-19-24 08:30AM	Lifeward Announces the Appointment of Mike Swinford to its Board of Directors (GlobeNewswire)
Apr-12-24 08:30AM	Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton (GlobeNewswire)
Apr-01-24 04:30PM	Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate (GlobeNewswire)
Mar-24-24 03:54PM	12 Best Biotech Penny Stocks to Invest In (Insider Monkey)
Mar-22-24 08:30AM	VA STAND Act introduced in the United States Senate (GlobeNewswire) +12.29%
Mar-13-24 11:45AM	Lifeward Announces Reverse Share Split (GlobeNewswire) -12.50%
Mar-08-24 08:30AM	ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy (GlobeNewswire)
Mar-01-24 12:00PM	All You Need to Know About ReWalk (LFWD) Rating Upgrade to Strong Buy (Zacks)
08:45AM	Lifeward announces the Centers for Medicare & Medicaid Services ( CMS ) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered (GlobeNewswire)
Feb-27-24 09:15AM	ReWalk Robotics (LFWD) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
08:00AM	Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-20-24 08:30AM	Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024 (GlobeNewswire)
Jan-29-24 08:00AM	ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward (GlobeNewswire) +6.07%
Jan-28-24 08:07PM	7 AgeTech Stocks to Profit From the Booming Longevity Market (InvestorPlace)
Jan-16-24 08:47AM	Sidoti Events, LLC's Virtual January Micro-Cap Conference (ACCESSWIRE)
Jan-12-24 08:30AM	ReWalk Robotics Expands Direct Sales Coverage to Canada (GlobeNewswire)
Jan-11-24 05:00PM	ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17 (GlobeNewswire)

Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lynch Jeannine	VP of Market Access & Strategy	Sep 02 '25	Sale	0.64	1,591	1,018	46,067	Sep 04 05:07 PM
Jasinski Lawrence J	Chief Executive Officer	May 21 '25	Sale	1.26	1,909	2,405	98,728	May 22 04:29 PM

LMAT Lemaitre Vascular Inc daily Stock Chart

Peers: ABT ISRG JNJ BSX EW MDT SYK COO HOLX XRAY

| Held by: IJR SDVY VTI IWM VXF SPSM IWO IJT VIG SLYG

Index	RUT	P/E	37.62	EPS (ttm)	2.32	Insider Own	8.24%	Shs Outstand	22.68M	Perf Week	2.88%
Market Cap	1.98B	Forward P/E	33.83	EPS next Y	2.58	Insider Trans	-6.12%	Shs Float	20.82M	Perf Month	4.38%
Enterprise Value	1.83B	PEG	2.50	EPS next Q	0.66	Inst Own	93.11%	Short Float	5.90%	Perf Quarter	1.33%
Income	53.34M	P/S	8.23	EPS this Y	26.77%	Inst Trans	-0.48%	Short Ratio	7.21	Perf Half Y	-7.26%
Sales	240.87M	P/B	5.23	EPS next Y	5.61%	ROA	10.94%	Short Interest	1.23M	Perf YTD	7.79%
Book/sh	16.71	P/C	5.78	EPS next 5Y	13.52%	ROE	15.02%	52W High	105.55 -17.18%	Perf Year	-11.28%
Cash/sh	15.12	P/FCF	29.94	EPS past 3/5Y	15.55% 16.99%	ROIC	9.49%	52W Low	71.42 22.40%	Perf 3Y	80.66%
Dividend Est.	0.80 (0.92%)	EV/EBITDA	25.28	Sales past 3/5Y	12.50% 13.40%	Gross Margin	69.18%	Volatility	2.65% 2.96%	Perf 5Y	81.90%
Dividend TTM	0.80 (0.92%)	EV/Sales	7.58	EPS Y/Y TTM	27.98%	Oper. Margin	25.74%	ATR (14)	2.36	Perf 10Y	498.77%
Dividend Ex-Date	Nov 20, 2025	Quick Ratio	11.45	Sales Y/Y TTM	13.07%	Profit Margin	22.14%	RSI (14)	57.85	Recom	1.91
Dividend Gr. 3/5Y	13.30% 13.49%	Current Ratio	13.22	EPS Q/Q	54.29%	SMA20	1.96%	Beta	0.70	Target Price	103.67
Payout	33.10%	Debt/Eq	0.49	Sales Q/Q	11.36%	SMA50	3.52%	Rel Volume	0.76	Prev Close	86.99
Employees	664	LT Debt/Eq	0.48	Earnings	Nov 06 AMC	SMA200	1.14%	Avg Volume	170.35K	Price	87.42
IPO	Oct 19, 2006	Option/Short	Yes / Yes	EPS/Sales Surpr.	32.56% -1.82%	Trades		Volume	129,975	Change	0.49%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-25	Upgrade	Barrington Research	Mkt Perform → Outperform	$95
Feb-28-25	Downgrade	Oppenheimer	Outperform → Perform
Feb-28-25	Downgrade	Barrington Research	Outperform → Mkt Perform
Feb-13-25	Initiated	Wells Fargo	Equal Weight	$95
Oct-15-24	Initiated	Cantor Fitzgerald	Neutral	$96
Aug-02-24	Resumed	Lake Street	Buy	$85 → $105
May-31-24	Resumed	ROTH MKM	Buy	$100
Apr-26-24	Upgrade	Stifel	Hold → Buy	$59 → $75
Feb-06-24	Resumed	KeyBanc Capital Markets	Sector Weight
Oct-23-23	Initiated	JMP Securities	Mkt Outperform	$60
Sep-06-23	Initiated	Oppenheimer	Outperform	$70
Aug-03-23	Downgrade	Jefferies	Buy → Hold	$63 → $67
May-03-23	Upgrade	Barrington Research	Mkt Perform → Outperform	$62
Oct-28-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Sep-16-21	Initiated	Jefferies	Buy	$70
Feb-12-21	Initiated	KeyBanc Capital Markets	Sector Weight
Mar-16-20	Upgrade	Sidoti	Neutral → Buy
Oct-24-19	Upgrade	Lake Street	Hold → Buy	$40
Oct-24-19	Downgrade	First Analysis Sec	Strong Buy → Outperform	$37 → $40
Oct-14-19	Upgrade	First Analysis Sec	Outperform → Strong Buy	$37

Show Previous Ratings

Feb-04-26 11:35PM	3 Small-Cap Stocks We Keep Off Our Radar (StockStory)
Jan-11-26 11:35PM	1 Cash-Producing Stock with Solid Fundamentals and 2 We Ignore (StockStory)
Dec-24-25 10:35PM	Reflecting On Surgical Equipment & Consumables - Specialty Stocks' Q3 Earnings: LeMaitre (NASDAQ:LMAT) (StockStory)
Dec-17-25 11:31PM	1 Small-Cap Stock to Target This Week and 2 That Underwhelm (StockStory)
Dec-02-25 10:02AM	Zacks.com featured highlights include Life Time, Cardinal Health, LeMaitre Vascular and Flowserve (Zacks)
08:02AM	Loading…
Dec-01-25 08:02AM	4 Stocks With High Coverage Ratios Offer Safer Bets Going Into 2026 (Zacks)
Nov-27-25 11:02PM	1 Reason LMAT is Risky and 1 Stock to Buy Instead (StockStory)
12:45PM	Here is Why Growth Investors Should Buy LeMaitre (LMAT) Now (Zacks)
Nov-24-25 06:17AM	3 Healthcare Stocks We Steer Clear Of (StockStory)
Nov-14-25 06:48AM	New Strong Buy Stocks for November 14th (Zacks)
Nov-13-25 12:32AM	5 Must-Read Analyst Questions From LeMaitre's Q3 Earnings Call (StockStory)
Nov-12-25 04:13PM	LeMaitre to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-11-25 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook LeMaitre (LMAT) (Zacks)
Nov-07-25 09:10AM	LMAT Q3 Deep Dive: Pricing and Margin Expansion Offset by Cautious Growth Outlook (StockStory)
12:08AM	LeMaitre Vascular Inc (LMAT) Q3 2025 Earnings Call Highlights: Strong Organic Sales Growth Amid ... (GuruFocus.com)
08:00PM	Loading…
Nov-06-25 08:00PM	LeMaitre Vascular (LMAT) Q3 Earnings Surpass Estimates (Zacks)
06:57PM	LeMaitre: Q3 Earnings Snapshot (Associated Press Finance)
04:24PM	LeMaitre (NASDAQ:LMAT) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
04:05PM	LeMaitre Q3 2025 Financial Results (GlobeNewswire)
Nov-04-25 10:08PM	LeMaitre Earnings: What To Look For From LMAT (StockStory)
Nov-03-25 12:08PM	Can Strength in Rental Business Drive INFU Stock Before Q3 Earnings? (Zacks)
Oct-30-25 09:23AM	Capricor (CAPR) Moves 12.0% Higher: Will This Strength Last? (Zacks)
Oct-22-25 11:40AM	PHG or LMAT: Which Is the Better Value Stock Right Now? (Zacks)
Oct-09-25 05:53PM	LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025 (GlobeNewswire)
Oct-06-25 11:34PM	Surgical Equipment & Consumables - Specialty Stocks Q2 Earnings Review: LeMaitre (NASDAQ:LMAT) Shines (StockStory)
Sep-30-25 12:04AM	3 Reasons LMAT is Risky and 1 Stock to Buy Instead (StockStory)
Sep-11-25 11:12AM	LeMaitre Vascular, Inc. (LMAT) Gains Edge in Niche Vascular Device Market (Insider Monkey)
Sep-03-25 02:46PM	Why LeMaitre (LMAT) Stock Is Down Today (StockStory)
Aug-28-25 04:35PM	LeMaitre to Participate at Upcoming Investor Conferences in September (GlobeNewswire)
Aug-27-25 12:45PM	Is LeMaitre (LMAT) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
08:49AM	Loading…
Aug-25-25 08:49AM	NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve (Zacks)
Aug-22-25 01:37PM	NVCR Stock Slips Despite PMA Application to Treat Pancreatic Cancer (Zacks)
Aug-12-25 11:59PM	5 Revealing Analyst Questions From LeMaitre's Q2 Earnings Call (StockStory)
11:41PM	LMAT Q2 Deep Dive: International Expansion and Product Momentum Drive Upbeat Outlook (StockStory)
Aug-11-25 12:45PM	LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
Aug-06-25 01:20PM	Why LeMaitre (LMAT) Stock Is Trading Up Today (StockStory) +8.91%
03:33AM	LeMaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ... (GuruFocus.com)
Aug-05-25 06:15PM	LeMaitre Vascular (LMAT) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:10PM	LeMaitre (NASDAQ:LMAT) Exceeds Q2 Expectations, Full-Year Sales Guidance is Optimistic (StockStory)
05:11PM	LeMaitre: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	LeMaitre Q2 2025 Financial Results (GlobeNewswire)
Aug-04-25 11:40AM	PAHC vs. LMAT: Which Stock Should Value Investors Buy Now? (Zacks)
09:37AM	LeMaitre Vascular Inc (LMAT) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Aug-03-25 11:17PM	LeMaitre (LMAT) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
Jul-17-25 12:09AM	2 Reasons to Avoid LMAT and 1 Stock to Buy Instead (StockStory)
Jul-08-25 04:04PM	LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025 (GlobeNewswire)
Jun-26-25 04:19AM	5 Must-Read Analyst Questions From LeMaitre's Q1 Earnings Call (StockStory)
Jun-16-25 12:37AM	1 Small-Cap Stock with Exciting Potential and 2 to Keep Off Your Radar (StockStory)
Jun-09-25 10:52PM	Anteris Appoints David Roberts and Gregory Moss to its Board of Directors (GlobeNewswire)
May-16-25 06:35AM	LMAT Q1 Earnings Call: Sales Growth Outpaces Expectations, Margin Pressures Addressed (StockStory)
May-09-25 12:34AM	1 Cash-Heavy Stock That Stand Out and 2 to Question (StockStory)
May-05-25 04:39PM	LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference (GlobeNewswire)
May-01-25 11:17PM	LeMaitre Vascular, Inc. (LMAT) Q1 2025 Earnings Call Transcript (Seeking Alpha) -12.79%
05:20PM	LeMaitre Vascular (LMAT) Lags Q1 Earnings Estimates (Zacks)
04:26PM	LeMaitre: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	LeMaitre Q1 2025 Financial Results (GlobeNewswire)
Apr-28-25 09:08AM	1 Profitable Stock with Impressive Fundamentals and 2 to Steer Clear Of (StockStory)
Apr-23-25 06:12PM	Cramer on LeMaitre Vascular (LMAT): "A Great Under-the-Radar Medical Device Stock" (Insider Monkey)
Apr-22-25 11:30AM	BD Stock Down Despite Monitoring Platform Launch to Boost Patient Care (Zacks)
Apr-21-25 08:57AM	FitLife Brands (FTLF) Surges 13.1%: Is This an Indication of Further Gains? (Zacks)
06:30AM	The Elephant In The Room - March Dividend Income Report (Seeking Alpha)
Apr-17-25 05:03AM	Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks (StockStory)
Apr-14-25 09:48AM	BAX Stock Declines Despite Latest Product Launch Boosting Patient Care (Zacks)
Apr-10-25 11:37AM	LeMaitre (LMAT) Soars 7.7%: Is Further Upside Left in the Stock? (Zacks)
Apr-07-25 03:56PM	LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025 (GlobeNewswire)
Apr-04-25 08:27AM	4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues (Zacks)
07:47AM	Small-Cap Dividend Stocks: Hidden Gems Or High-Risk Plays? - Top U.S. And Canadian Ones (Seeking Alpha)
Apr-01-25 03:20PM	LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-31-25 05:13AM	2 Reasons to Avoid LMAT and 1 Stock to Buy Instead (StockStory)
Mar-29-25 10:30AM	Stocks Falling On Earnings - What To Do? February Dividend Income Report (Seeking Alpha)
Mar-25-25 12:45PM	3 Reasons Growth Investors Will Love LeMaitre (LMAT) (Zacks)
Mar-22-25 12:31AM	Dividend Champion, Contender, And Challenger Highlights: Week Of March 23 (SeekingAlpha)
Mar-20-25 09:05AM	Invesco Health Care Fund Q4 2024 Commentary (SeekingAlpha)
09:00AM	Precision Optics Appoints Joseph P. Pellegrino, Jr. to Board of Directors (GlobeNewswire)
Mar-13-25 09:35AM	Down -15.37% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround (Zacks)
Mar-03-25 05:06PM	LeMaitre to Participate at Upcoming Investor Conferences in March (GlobeNewswire)
12:00PM	LeMaitre (LMAT) Upgraded to Buy: Here's What You Should Know (Zacks)
Feb-28-25 02:40AM	LeMaitre Vascular Inc (LMAT) Q4 2024 Earnings Call Highlights: Strong Sales Growth and ... (GuruFocus.com) -8.07%
Feb-27-25 06:45PM	LeMaitre Vascular (LMAT) Meets Q4 Earnings Estimates (Zacks)
05:47PM	LeMaitre: Q4 Earnings Snapshot (Associated Press Finance)
04:32PM	LeMaitre (NASDAQ:LMAT) Misses Q4 Sales Targets, Stock Drops 11% (StockStory)
04:05PM	LeMaitre Q4 2024 Financial Results (GlobeNewswire)
Feb-26-25 08:05AM	What To Expect From LeMaitres (LMAT) Q4 Earnings (StockStory)
07:33AM	Earnings To Watch: LeMaitre Vascular Inc (LMAT) Reports Q4 2024 Result (GuruFocus.com)
Feb-25-25 02:52PM	Medtronic Stock Gets IBD Rating Lift (Investor's Business Daily)
Jan-27-25 03:15PM	LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025 (GlobeNewswire)
Dec-16-24 11:28PM	LeMaitre Vascular Prices $150 Million Convertible Senior Notes (GlobeNewswire) -8.53%
07:57AM	LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering (GlobeNewswire)
Dec-11-24 02:59PM	Inari Medical Stock Gets RS Rating Upgrade (Investor's Business Daily)
Dec-03-24 02:51PM	Novocure Stock Earns 96 RS Rating (Investor's Business Daily)
Nov-25-24 05:20PM	LeMaitre to Participate at Upcoming Investor Conferences in December (GlobeNewswire)
Nov-01-24 04:47PM	LeMaitre to Participate at Upcoming Investor Conferences in November (GlobeNewswire) +7.34%
11:02AM	LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ... (GuruFocus.com)
Oct-31-24 05:20PM	LeMaitre Vascular (LMAT) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
04:15PM	LeMaitre: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	LeMaitre Q3 2024 Financial Results (GlobeNewswire)
Oct-15-24 04:34PM	LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024 (GlobeNewswire)
Oct-09-24 03:52PM	LeMaitre Vascular Inc (LMAT) Q2 2024 Earnings Call Highlights: Strong Growth Across Key Metrics ... (GuruFocus.com)
Sep-23-24 12:00PM	All You Need to Know About LeMaitre (LMAT) Rating Upgrade to Strong Buy (Zacks)
Sep-16-24 12:28PM	LeMaitre Vascular (LMAT) Surged Due to Robust Global Markets (Insider Monkey)

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Roberts David B	President and Director	Feb 05 '26	Option Exercise	37.32	2,679	99,979	24,930	Feb 06 04:48 PM
Kamke Trent G	Senior V. P., Operations	Jan 08 '26	Option Exercise	42.67	2,344	100,018	6,761	Jan 12 05:16 PM
LeMaitre George W	Chairman and CEO	Dec 12 '25	Option Exercise	47.28	26,223	1,239,769	1,695,652	Dec 15 06:14 PM
LeMaitre George W	Chairman and CEO	Dec 11 '25	Option Exercise	0.00	54	0	1,670,159	Dec 15 06:14 PM
Roberts David B	President and Director	Dec 12 '25	Option Exercise	0.00	36	0	22,837	Dec 15 06:13 PM
Roberts David B	President and Director	Dec 11 '25	Option Exercise	0.00	25	0	23,116	Dec 15 06:13 PM
Kamke Trent G	Senior V. P., Operations	Dec 12 '25	Option Exercise	0.00	16	0	4,589	Dec 15 06:12 PM
Kamke Trent G	Senior V. P., Operations	Dec 11 '25	Option Exercise	0.00	11	0	4,671	Dec 15 06:12 PM
Pellegrino Joseph P JR	Director	Dec 12 '25	Option Exercise	0.00	36	0	10,183	Dec 15 06:12 PM
Pellegrino Joseph P JR	Director	Dec 11 '25	Option Exercise	0.00	25	0	10,147	Dec 15 06:12 PM
SHADAN MARTHA	Director	Dec 12 '25	Option Exercise	0.00	10	0	2,485	Dec 15 06:11 PM
Ross Bridget A	Director	Dec 12 '25	Option Exercise	0.00	10	0	3,465	Dec 15 06:10 PM
O'Connor John James	Director	Dec 12 '25	Option Exercise	0.00	10	0	62,350	Dec 15 06:10 PM
Jasinski Lawrence J	Director	Dec 12 '25	Option Exercise	0.00	10	0	5,322	Dec 15 06:09 PM
Roush John A	Director	Dec 12 '25	Option Exercise	0.00	10	0	3,465	Dec 15 06:07 PM
LeMaitre George W	Chairman and CEO	Dec 08 '25	Option Exercise	0.00	46	0	1,665,053	Dec 10 07:28 PM
Roberts David B	President and Director	Dec 08 '25	Option Exercise	0.00	20	0	21,821	Dec 10 07:27 PM
Kamke Trent G	Senior V. P., Operations	Dec 08 '25	Option Exercise	0.00	9	0	3,647	Dec 10 07:27 PM
Pellegrino Joseph P JR	Director	Dec 08 '25	Option Exercise	0.00	20	0	9,589	Dec 10 07:27 PM
Jasinski Lawrence J	Director	Dec 08 '25	Option Exercise	0.00	5	0	4,779	Dec 10 07:27 PM
O'Connor John James	Director	Dec 08 '25	Option Exercise	0.00	5	0	61,807	Dec 10 07:26 PM
Ross Bridget A	Director	Dec 08 '25	Option Exercise	0.00	5	0	2,922	Dec 10 07:26 PM
Roush John A	Director	Dec 08 '25	Option Exercise	0.00	5	0	2,922	Dec 10 07:26 PM
SHADAN MARTHA	Director	Dec 08 '25	Option Exercise	0.00	5	0	1,942	Dec 10 07:26 PM
Kamke Trent G	Senior V. P., Operations	Dec 06 '25	Option Exercise	0.00	2	0	3,712	Dec 08 08:33 PM
Roberts David B	President and Director	Dec 06 '25	Option Exercise	0.00	3	0	21,921	Dec 08 08:32 PM
Pellegrino Joseph P JR	Director	Dec 06 '25	Option Exercise	0.00	3	0	9,569	Dec 08 08:25 PM
O'Connor John James	Director	Dec 06 '25	Option Exercise	0.00	1	0	61,802	Dec 08 08:22 PM
Jasinski Lawrence J	Director	Dec 06 '25	Option Exercise	0.00	1	0	4,774	Dec 08 08:21 PM
Roush John A	Director	Dec 06 '25	Option Exercise	0.00	1	0	2,917	Dec 08 08:20 PM
Ross Bridget A	Director	Dec 06 '25	Option Exercise	0.00	1	0	2,917	Dec 08 08:20 PM
SHADAN MARTHA	Director	Dec 06 '25	Option Exercise	0.00	1	0	1,937	Dec 08 08:19 PM
LeMaitre George W	Chairman and CEO	Dec 06 '25	Option Exercise	0.00	11	0	1,665,585	Dec 08 08:18 PM
Kamke Trent G	Senior V. P., Operations	Dec 02 '25	Option Exercise	0.00	10	0	3,763	Dec 03 07:41 PM
Pellegrino Joseph P JR	Director	Dec 02 '25	Option Exercise	0.00	15	0	9,581	Dec 03 07:39 PM
LeMaitre George W	Chairman and CEO	Dec 02 '25	Option Exercise	0.00	45	0	1,666,029	Dec 03 07:39 PM
Roberts David B	President and Director	Dec 02 '25	Option Exercise	0.00	15	0	22,025	Dec 03 07:38 PM
O'Connor John James	Director	Nov 21 '25	Option Exercise	37.29	7,500	279,675	64,801	Nov 21 05:55 PM
LeMaitre George W	Chairman and CEO	Nov 20 '25	Option Exercise	41.02	2,681	109,975	1,665,984	Nov 21 05:36 PM
Jasinski Lawrence J	Director	Aug 12 '25	Sale	92.78	976	90,553	4,773	Aug 14 04:30 PM
Roberts David B	President and Director	Aug 11 '25	Option Exercise	37.27	10,815	403,069	24,689	Aug 13 05:08 PM
Roberts David B	President and Director	Aug 11 '25	Sale	92.39	10,815	999,173	17,976	Aug 13 05:08 PM
Ross Bridget A	Director	Aug 08 '25	Option Exercise	37.29	2,500	93,225	5,416	Aug 13 08:55 AM
Ross Bridget A	Director	Aug 08 '25	Sale	94.00	2,500	235,000	2,916	Aug 13 08:55 AM
Roush John A	Director	Aug 11 '25	Option Exercise	37.29	6,561	244,660	9,477	Aug 13 08:54 AM
Roush John A	Director	Aug 08 '25	Option Exercise	37.29	939	35,015	3,855	Aug 13 08:54 AM
Roush John A	Director	Aug 11 '25	Sale	92.55	6,561	607,231	2,916	Aug 13 08:54 AM
Roush John A	Director	Aug 08 '25	Sale	93.49	939	87,784	2,916	Aug 13 08:54 AM
Lawrence J. Jasinski	Director	Aug 12 '25	Proposed Sale	92.78	976	90,553		Aug 12 04:07 PM
JOHN ADAM ROUSH	Director	Aug 11 '25	Proposed Sale	92.55	6,561	607,230		Aug 11 04:07 PM
DAVID ROBERTS	Officer	Aug 11 '25	Proposed Sale	92.39	10,815	999,173		Aug 11 04:06 PM
LeMaitre George W	Chairman and CEO	Aug 06 '25	Sale	93.51	100,000	9,350,530	1,727,003	Aug 08 05:48 PM
JOHN ADAM ROUSH	Director	Aug 08 '25	Proposed Sale	93.49	939	87,784		Aug 08 05:17 PM
BRIDGET A ROSS	Director	Aug 08 '25	Proposed Sale	94.00	2,500	235,000		Aug 08 04:22 PM
LeMaitre George W	Officer	Aug 06 '25	Proposed Sale	93.51	100,000	9,350,530		Aug 06 11:42 AM
LeMaitre George W	Chairman and CEO	May 20 '25	Option Exercise	44.64	34,619	1,545,293	1,831,402	May 20 07:11 PM
LeMaitre George W	Chairman and CEO	May 19 '25	Sale	85.79	76,868	6,594,334	1,796,783	May 20 07:11 PM
LeMaitre George W	Chairman and CEO	May 16 '25	Sale	84.77	18,733	1,587,923	1,873,651	May 20 07:11 PM
LeMaitre George W	Chairman and CEO	May 20 '25	Sale	85.10	4,399	374,374	1,827,003	May 20 07:11 PM
Ross Bridget A	Director	May 12 '25	Option Exercise	30.00	3,750	112,500	6,666	May 14 04:03 PM
Ross Bridget A	Director	May 12 '25	Sale	83.20	3,750	312,000	2,916	May 14 04:03 PM
Ross Bridget A	Director	May 12 '25	Proposed Sale	83.20	3,750	312,000		May 12 05:42 PM
Kamke Trent G	Senior V. P., Operations	Mar 14 '25	Option Exercise	36.92	2,709	100,006	3,753	Mar 14 04:53 PM
Kamke Trent G	Senior V. P., Operations	Mar 12 '25	Option Exercise	23.56	2,009	47,332	7,573	Mar 14 04:53 PM
Kamke Trent G	Senior V. P., Operations	Mar 13 '25	Sale	79.66	4,520	360,073	1,044	Mar 14 04:53 PM
Kamke Trent G	Senior V. P., Operations	Mar 12 '25	Sale	82.12	2,009	164,979	5,564	Mar 14 04:53 PM
TRENT G KAMKE	Officer	Mar 13 '25	Proposed Sale	79.66	4,520	360,074		Mar 13 04:26 PM
Kamke Trent G	Officer	Mar 12 '25	Proposed Sale	82.12	2,009	164,979		Mar 12 05:24 PM
Roberts David B	President and Director	Mar 07 '25	Option Exercise	35.48	2,818	99,983	17,976	Mar 11 04:34 PM
Jasinski Lawrence J	Director	Mar 04 '25	Sale	92.00	3,142	289,064	2,607	Mar 06 05:16 PM
LeMaitre George W	Officer	Mar 05 '25	Proposed Sale	89.46	200,000	17,892,000		Mar 05 12:46 PM
SHADAN MARTHA	Director	Feb 28 '25	Option Exercise	0.00	1	0	1,936	Mar 04 07:32 PM
Roush John A	Director	Feb 28 '25	Option Exercise	0.00	1	0	2,916	Mar 04 07:30 PM
Ross Bridget A	Director	Feb 28 '25	Option Exercise	0.00	1	0	2,916	Mar 04 07:25 PM
O'Connor John James	Director	Feb 28 '25	Option Exercise	0.00	1	0	57,301	Mar 04 07:23 PM
Jasinski Lawrence J	Director	Feb 28 '25	Option Exercise	0.00	1	0	5,749	Mar 04 07:20 PM
Kamke Trent G	Senior V. P., Operations	Feb 28 '25	Option Exercise	0.00	2	0	5,384	Mar 04 07:14 PM
Pellegrino Joseph P JR	Chief Financial Officer	Feb 28 '25	Option Exercise	0.00	5	0	9,769	Mar 04 07:10 PM
Roberts David B	President and Director	Feb 28 '25	Option Exercise	0.00	5	0	15,361	Mar 04 07:04 PM
LeMaitre George W	Chairman and CEO	Feb 28 '25	Option Exercise	0.00	11	0	1,892,831	Mar 04 06:53 PM
Jasinski Lawrence J	Director	Mar 04 '25	Proposed Sale	92.00	3,142	289,064		Mar 04 04:49 PM

LFWD

Lifeward Ltd

LMAT

Lemaitre Vascular Inc

Upgrade your FINVIZ experience